Embrace Change Acquisition Corp. (EMCWF)

Embrace Change Acquisition Corp. issued three classes of securities when it raised capital in its August 2022 IPO: ordinary shares, subscription rights, and warrants. The warrants, which traded under the symbol EMCGW on Nasdaq until delisting, represent a leveraged way for investors to gain exposure to the underlying SPAC deal. A warrant is a contract that grants its holder the right to purchase a share of the combined company at a pre-agreed price (the strike price) within a specified time window. Unlike a share, which represents direct ownership, a warrant is a derivative—its value depends entirely on what the underlying share does.

In Embrace Change’s structure, each warrant gave the holder the right to purchase one ordinary share at a fixed strike price. The terms reflected standard SPAC warrant design: if the combined company’s share price climbed above the strike price, warrant holders had incentive to exercise (pay the strike, receive a share). If the share price fell below the strike, warrants would become worthless because no rational investor would pay the strike price to buy a share at that price when the open market was cheaper. The warrant holder’s bet was that the combined company—in this case, the hypothetical Tianji Tire merged entity—would trade above the strike price, unlocking value.

The appeal of warrants is leverage. A warrant costs less than a full share but gives proportional upside if the company appreciates. If a share appreciates ten percent, a warrant might appreciate thirty percent (or vanish entirely if things go the wrong direction). This leverage attracts investors with higher risk tolerance and smaller capital bases. In the SPAC context, warrants also serve a practical purpose: they allow insiders and sponsors to benefit from a deal without diluting public shareholders as much as they would if founders simply received additional shares.

Embrace Change’s warrants, like the underlying SPAC, faced the challenge of time. A SPAC has a deadline to complete its merger. If the deadline is missed or the deal is liquidated before closing, warrant holders are typically left with a right to purchase shares in a liquidated shell company—a right with no value. As Embrace Change faced delisting in mid-2025 and the trust account dwindled due to shareholder redemptions, the warrants’ value eroded. Investors who bought warrants at the IPO were betting on a successful Tianji Tire merger and anticipated appreciation. The failure to complete the deal before the delisting deadline rendered that bet unresolved.

The broader economics of a SPAC warrant depend on two unknowns: the probability the merger closes successfully and the expected value of the combined company on the day it becomes public (or shortly thereafter). For Embrace Change, the announced merger with Tianji Tire valued the combined entity at $450 million. If the deal had closed and Tianji Tire shares began trading, warrant holders would know immediately whether their right to purchase shares at the strike price was “in the money” (the stock price above the strike) or “out of the money” (below). At that point, warrants would either be exercised, held for continued appreciation, or left to expire worthless.

Because the deal never closed, warrant holders were left in limbo. They could not exercise (there was no combined company to buy shares in). They could not sell into a liquid market (trading was suspended). If and when the liquidation finalizes, warrants typically receive only residual value—whatever cash remains in the trust after returning capital to preferred shareholders and redeeming public shares at their subscription price. This is why warrants in a failed SPAC are often worth cents on the dollar even if the SPAC raised tens of millions.

The warrant structure reveals a fundamental risk in SPAC investing: the success or failure of the deal and the subsequent market performance of the combined company are binary events. Unlike operating a traditional stock in a mature company, where you can hold through cycles and improve over years, SPAC warrant holders face time decay and deal risk. Every month that passes without a closed merger erodes the time value of the warrant. Every month brings the SPAC closer to its liquidation date. Embrace Change’s warrant holders learned this lesson late: they purchased leverage on a promised merger that never executed within the window allowed.

Investors in SPAC warrants are ultimately making a bet on two things happening in sequence: a successful merger close and a positive market reception for the combined company. When the first event fails, the second becomes irrelevant. The EMCWF warrants, in their failure to close, underscore the leverage and time-compression risk embedded in every SPAC structure. They are tools that magnify returns in the happy path and vanish in the sad path, with little middle ground.